As of 4:00pm ET
| -0.17 / -0.84%|
The 3 analysts offering 12-month price forecasts for AngioDynamics Inc have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 16.00. The median estimate represents a -14.87% decrease from the last price of 19.97.
The current consensus among 4 polled investment analysts is to Hold stock in AngioDynamics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.